Growth hormone-secretagogues such as Ipamorelin may trigger insulin release from pancreatic cells via pancreatic cells calcium channels
"The companies and the FDA, no one's identified an endgame with these drugs," Kessler says
The compound selectively reduces mPGES-1 activity, differentiating it from current endometriosis therapies like celecoxib and NSAIDs, which act further upstream in the prostaglandin pathway, reducing the activity of all prostaglandin synthases
The closest FDA-approved IGF-1 product is mecasermin (Increlex) , native recombinant human IGF-1, approved only for the long-term treatment of growth failure in pediatric patients with severe primary IGF-1 deficiency or GH gene deletion with neutralizing antibodies
AstraZeneca plc GlaxoSmithKline plc Boehringer Ingelheim International GmbH Pfizer Inc
Melanotan II and the Features of Autism In a common mouse model of Autism Spectrum Disorder (ASD), administration of MT-2 reversed certain features of Autism